C

Centennial Medical Group | Elkridge, MD

Research site

(Unclaimed)

Location

8186 Lark Brown Road, Elkridge, Maryland, United States of America

Site insights

Top conditions

Top treatments

LY3298176

Semaglutide

Tirzepatide

Testosterone

Sitagliptin

AD109

JNJ-42847922

IHL-42X

NN0519-0130

Pimodivir

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 54 total trials

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388...

Active, not recruiting

Type 2 Diabetes Mellitus (T2DM)

Overweight or Obese

Drug: CT-388

Drug: Placebo

A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO)

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting

Overweight

Obesity

Drug: Placebo

Drug: Tirzepatide

RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA (REPOSA)

The goal of this randomised, double-blind phase II/III clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive...

Active, not recruiting

Obstructive Sleep Apnea

Drug: Acetazolamide

Drug: IHL-42X Low Dose

Locations recently updated

Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS) (PALISADE)

The purpose of AROAPOC3-3001 is to evaluate the efficacy and safety of ARO-APOC3 (plozasiran) in adult participants with familial chylomicronemia syn...

Active, not recruiting

Familial Chylomicronemia

Drug: Plozasiran

Drug: Placebo